Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19 – Preliminary report - The, REMAP-CAP Investigators; Gordon, A; Mouncey, P; Al-Beidh, F; Rowan, K; Nichol, A; Arabi, Y; Annane, D; Beane, A; van, Bentum-Puijk W; Berry, L; Bhimani, Z; et al. (Cold Spring Harbor Laboratory, 2021)